Global Sourcing & Market Overview: Pharmaceutical Intermediate CAS 138229-59-1

Market Positioning & Commercial Overview

In the rapidly evolving oncology and fine chemical sectors, maintaining reliable access to key molecular precursors is essential for keeping therapy pipelines moving forward and stabilizing API manufacturing schedules. CAS No. 138229-59-1—known commercially as Methyl 3-formyl-2-nitrobenzoate—is a high-value core building block primarily utilized in the synthesis of advanced targeted therapeutics, including PARP inhibitor cancer therapies like Niraparib and hypoxia-inducible factor (HIF) stabilizers like Roxadustat.

As targeted oncology treatments expand globally, demand for key upstream intermediates has surged. Sourcing this pre-assembled aromatic intermediate allows drug manufacturers to streamline multi-step laboratory routes into efficient industrial production campaigns, lowering overall cost of goods sold (COGS) and speeding up commercial scale-up timelines.

Primary Commercial Drivers & Downstream Applications

Targeted Oncology Pipeline Support:

Serves as a direct key precursor for PARP inhibitors used in targeted treatments for ovarian, breast, and prostate cancers.

Therapeutic Expansion:

Acts as an essential intermediate in novel therapies targeting cellular hypoxia, kidney disease-related anemia, and other specialized small-molecule drug platforms.

Commercial Scale Efficiency:

Sourcing a pre-formed dual-functional intermediate accelerates reaction cycles, reduces downstream purification steps, and improves overall campaign yield in active pharmaceutical ingredient (API) manufacturing.

Supply Chain Management & Strategic Sourcing

Procuring campaign-scale quantities of CAS 138229-59-1 requires careful supply chain planning to navigate market demand shifts and global trade logistics.

Demand Forecasting & Campaign Alignment

Demand for high-purity pharmaceutical intermediates closely tracks clinical trial progression and commercial API production schedules. Forward-thinking procurement teams structure multi-quarter delivery contracts 3 to 6 months in advance to hedge against spot-market price volatility and ensure uninterrupted raw material availability during major manufacturing runs.

Export Packaging & Logistics Control

To ensure complete product integrity during cross-border transit and long-term warehouse storage, commercial shipments are packaged using industry-standard protective measures:

Protective Containment:

Heavy-duty fiber or plastic drums fitted with double polyethylene inner liners to shield the product from atmospheric humidity and contamination.

Transit Safety:

Heat-treated, shrink-wrapped palletization designed for ocean container shipping and automated logistics handling.

Regulatory Compliance:

Full documentation including Safety Data Sheets (SDS), origin certificates, and custom clearance dossiers aligned with international freight regulations.

Storage Logistics & Handling Recommendations

Facility Controls:

Store original sealed containers in dedicated, dry, and well-ventilated warehouse environments maintained below 25 °C away from light and humidity.

Inventory Care:

Keep pallets elevated and isolated from strong oxidizing or reducing agents.

Workplace Hygiene:

Follow standard industrial chemical hygiene protocols, including local exhaust ventilation, protective gloves, safety glasses, and dust protection during bulk handling.

Why Partner with EASTFINE for Fine Chemical Intermediates

Securing reliable commercial allocations requires direct collaboration with an established primary producer capable of offering long-term supply security, batch-to-batch consistency, and transparent pricing.

Dual-Site Production Resilience

To protect global pharmaceutical partners from supply disruptions, regional maintenance halts, or localized shipping bottlenecks, EASTFINE operates two independent chemical manufacturing bases in Dalian and Heze:

Continuous Delivery Guarantees:

Multi-facility infrastructure ensures continuous product flow to keep downstream synthesis lines operating smoothly on schedule.

Flexible Order Volume:

Seamlessly scales production from pilot-stage evaluation batches to multi-ton commercial supply contracts.

Dedicated In-House R&D & Manufacturing

Backed by an experienced research staff holding 19 invention patents and 8 utility model patents, EASTFINE focuses on route optimization, waste reduction, and process productivity. Direct sourcing from the primary producer eliminates intermediary trading markups, ensuring highly competitive factory-direct pricing.

ISO Compliance & Comprehensive Quality Dossiers

Operating under certified ISO 9001, ISO 14001, and ISO 45001 management frameworks, EASTFINE supports every shipment with full Certificate of Analysis (COA) testing documentation, sample retention, and complete lot traceability required for global regulatory audits.

Conclusion & Commercial Inquiries

Methyl 3-formyl-2-nitrobenzoate (CAS No. 138229-59-1) is an indispensable building block for manufacturing high-value, modern pharmaceutical therapies. Partnering with a primary manufacturer like EASTFINE ensures the supply resilience, cost structure, and quality controls necessary to maintain a strong market position.

To request product samples, Certificates of Analysis, or commercial volume pricing, contact EASTFINE's sourcing team today.